Legal Representation
Attorney
Michael N. Mercanti
USPTO Deadlines
Next Deadline
2051 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-02-25)
Due Date
February 25, 2031
Grace Period Ends
August 25, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
19 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 26, 2025 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Feb 25, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Feb 25, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jan 7, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 7, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 1, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 11, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 10, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Dec 10, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 10, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 30, 2024 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Nov 11, 2024 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Nov 11, 2024 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Nov 2, 2024 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Nov 1, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 31, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 3, 2024 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jun 3, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 30, 2024 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Topical gels for medical and therapeutic use, namely medicinal preparations for local use for the treatment of genitourinary system disorders; Medicinal preparations for local use for the regeneration of vulvovaginal and uro-pelvic tissues; Medicinal preparations for local use for the treatment of stress-induced urinary incontinence; Medicinal preparations for local use for the treatment of vulvovaginal atrophy; Medicinal preparations for local use for the treatment of vulvodynia.
Classification
International Classes
005